These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2440683)

  • 1. Effects of intravenous sotalol, aprindine and the combination of sotalol and aprindine on chronic high frequency ventricular arrhythmias in man.
    Stroobandt R; Holvoet G; Verbeke N; Kesteloot H
    Eur Heart J; 1987 Apr; 8(4):372-7. PubMed ID: 2440683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of recurrent ventricular tachycardia and fibrillation with aprindine.
    Fasola AF; Noble RJ; Zipes DP
    Am J Cardiol; 1977 May; 39(6):903-9. PubMed ID: 67800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of the repetitive ventricular response: an index of long-term antiarrhythmic effectiveness of aprindine for ventricular tachycardia in man.
    Schaeffer AH; Greene HL; Reid PR
    Am J Cardiol; 1978 Dec; 42(6):1007-12. PubMed ID: 727128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of refractory arrhythmias by aprindine in patients with the Wolff-Parkinson-White syndrome.
    Reid PR; Greene HL; Varghese PJ
    Br Heart J; 1977 Dec; 39(12):1353-60. PubMed ID: 603737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sotalol, aprindine and the combination aprindine-sotalol on monophasic action potential duration.
    Stroobandt R; Brachmann J; Kesteloot H; Kübler W; Senges J
    Eur Heart J; 1986 Jan; 7(1):47-53. PubMed ID: 3956522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aprindine therapy for refractory ventricular tachycardia.
    Khan AH; Carleton RA; Chown M
    Arch Intern Med; 1983 Feb; 143(2):229-32. PubMed ID: 6824389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of intravenous aprindine on hemodynamics in patients with cardiac dysfunction and its pharmacodynamics in patients with premature ventricular contractions].
    Matsumoto N; Hayasaki K
    Kokyu To Junkan; 1990 Apr; 38(4):383-9. PubMed ID: 1694595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of extrasystoles using a new oral anti-arrhythmic agent Aprindine].
    Sterz H
    Acta Med Austriaca; 1974; 1(4):127-31. PubMed ID: 4142916
    [No Abstract]   [Full Text] [Related]  

  • 9. [Aprindine in the treatment of chronic premature ventricular contractions. Evaluations based on the two-way analysis of variance and linear regression analysis].
    Oyama Y; Kanda K; Kawasaki H
    Kokyu To Junkan; 1986 Mar; 34(3):309-13. PubMed ID: 2422714
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparison of the anti-arrhythmic effects of propafenone and aprindine in the treatment of refractory chronic ventricular arrhythmias. A randomized double-blind crossover study controlled with placebo].
    Purcaro A; Amici R; Ciampani N; Costantini C; Mocchegiani R; Pigini G
    G Ital Cardiol; 1983; 13(6):444-50. PubMed ID: 6357929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventricular tachycardia: prediction of response to oral aprindine with intravenous aprindine.
    Strasberg B; Palileo E; Prechel D; Bauernfeind R; Swiryn S; Wyndham CR; Dhingra RC; Kehoe R; Rosen KM
    Am J Cardiol; 1981 Mar; 47(3):676-82. PubMed ID: 6781325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of clinical efficacy and plasma levels of aprindine.
    Malini PL; Ambrosioni E; Bracchetti D; Magnani B
    Int J Clin Pharmacol Biopharm; 1979 Oct; 17(10):396-403. PubMed ID: 500254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aprindine for treatment of ventricular arrhythmias in the dog.
    Muir WW; Bonagura JD
    Am J Vet Res; 1982 Oct; 43(10):1815-9. PubMed ID: 7149383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolongation of cardiac conduction times by intravenous aprindine in man.
    Greene HL; Reid PR; Schaeffer AH
    Am J Cardiol; 1978 Dec; 42(6):1002-6. PubMed ID: 727127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term oral antiarrhythmic therapy with aprindine: effects on cardiac function and adverse effects.
    Tsutsui H; Araki H; Nagata Y; Nakamura M
    Clin Ther; 1984; 6(6):770-7. PubMed ID: 6509460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of aprindine on ventricular arrhthmias].
    Domínguez JF; Martín Sánchez JC; Ciscar A; Hidalgo M; Petit Guinovart M; Ballesta Barcons F
    Rev Esp Cardiol; 1975; 38(2):145-52. PubMed ID: 49071
    [No Abstract]   [Full Text] [Related]  

  • 17. Aprindine.
    Danilo P
    Am Heart J; 1979 Jan; 97(1):119-24. PubMed ID: 364967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Torsade des pointes and aprindine.
    Sideris DA; Kontoyannis DA; Moulopoulos SD
    Int J Cardiol; 1985 Apr; 7(4):413-6. PubMed ID: 2580805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies with aprindine.
    Zipes DP; Elharrar V; Gilmour RF; Heger JJ; Prystowsky EN
    Am Heart J; 1980 Dec; 100(6 Pt 2):1055-62. PubMed ID: 6255785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of intravenous moxaprindine on ventricular ectopic activity.
    Waleffe A; Guillaume D; Mary-Rabine L; Kulbertus H
    Acta Cardiol; 1980; 35(4):257-68. PubMed ID: 6971032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.